Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis
This study has been terminated.
( Interim Analysis showed that study continuation was futile. No safety concerns were raised during the trial. )
Study NCT00086684 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received on July 7, 2004. Last Updated on January 23, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Urinary Bladder Diseases
Interventions listed in this trial
Pentosan polysulfate sodium 100 mg
Additional drug interventions recognized in this trial
Pentosan Sulfuric Polyester
More general drug interventions related to this trial
Sponsors listed in this trial
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers